Mr. Charles Michael Beers Sr., PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 110 N Brown St, Chadbourn, NC 28431 Phone: 910-654-1701 |
Mr. Phillip Timothy Seamans, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 104 E 7th Ave, Chadbourn, NC 28431 Phone: 910-654-3143 Fax: 910-654-4144 |
News Archive
Merck, known as MSD outside the United States and Canada, and Astellas US LLC, the U.S. subsidiary of Astellas Pharma Inc. today announced that they have entered into an agreement under which Merck, through a subsidiary, will acquire the exclusive rights to develop and commercialize the investigational intravenous formulation of vernakalant (vernakalant i.v.) in Canada, Mexico and the United States from Astellas.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, today announced that patient enrollment was completed in March in its dermaPACEā¢ Phase III pivotal, randomized, double-blinded, sham controlled, multicenter clinical trial comparing its Pulsed Acoustic Cellular Expression technology, utilizing the dermaPACEā¢ tissue regeneration device, to sham control for the treatment of diabetic foot ulcers.
Winter can be especially hazardous to human health with frostbite and frostnip being among the more common hazards people are likely to encounter. Frostbite and frostnip occur when the human body is exposed to extremely low temperatures for a period of time without the proper clothing for the conditions. Extreme cold causes the blood vessels of the body to begin to narrow and constrict, reducing blood flow to the extremities, such as ears, the nose, hands and feet.
Researchers at Columbia University Medical Center and the State University of New York at Stony Brook (SUNY) have developed a groundbreaking technique to sneak therapeutic genes past the body's defenses, possibly clearing one of the largest hurdles to realizing the potentials of medically altering a patient's DNA.
› Verified 2 days ago